Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass

Gu YJ , Boonstra PW , Rijnsburger AA et al. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility. Ann Thorac Surg1998; 65: 1342-1347.

Defraigne JO , Pincemail J , Dekoster G et al. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery. Ann Thorac Surg2000; 70: 2075-2081.

Rubens FD , Labow RS , Lavallee GR et al. Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block co-polymer. Ann Thorac Surg1999; 67: 689-698.

Eberhart RC , Li J , Sly MK et al. Scintigraphic analysis of cell adhesion in oxygenators and internal organs. The 23rd Annual Meeting, Society for Biomaterials, New Orleans, LA, USA1997.

Tanaka M , Motomura T , Kawada M et al. Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA) - relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials2000; 21: 1471-1481.

Saito N , Motoyama S , Sawamoto J. Effect of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artificial Organs2000; 24: 547-554.

Schiel L , Burns S , Nogawa A et al. X coating: a new biopassive polymer coating. Can Perfusion2001; 11: 8-17.

Moen O , Hogasen K , Fosse E et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg1997; 63: 105-111.

Hsu LC. Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion2001; 16: 417-428.

Gunaydin S. Clinical performance and hemobiocompatibility of new polymer (poly2-methoxyethylacry-late) coated extracorporeal circuit - a comparative study. Ann Thorac Surg in press.

Gourlay T. Biomaterial development for cardiopulmonary bypass. Perfusion2001; 16: 381-390.

Horisberger J , Jegger D , Boone Y et al. Impact of a remote pump head on neonatal priming volumes. Perfusion1999; 14: 351-356.

De Somer F , Foubert L , Poelaert , Dujardin D , Van Nooten G , Francois K. Low extracorporeal priming volumes for infants: a benefit? Perfusion1996; 11: 445-460.

McCusker K , Vijay V , DeBois W et al. MAST system: a new condensed cardiopulmonary bypass circuit for adult cardiac surgery. Perfusion2001; 16: 447-452.

McCusker K , Vijay V , Helm V et al. Clinical outcomes of complete X-coating circuit in MAST condensed bypass setting. J Extra Corporeal Technol2002; 34: 78-81.

Harig F , Hohenstein B , von der Emde J et al. Modulating IL-6 and IL-10 levels of pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock2001; 16(Suppl 1): 33-38.

Harig F , Feyrer R , Mahmoud FO et al. Reducing the post-pump syndrome by using heparin-coated circuit, steroids, or aprotinin. Thorac Cardiovasc Surg1999; 47: 111-118.

Gott JP , Cooper WA , Schmidt FE Jr et al. Modifying risk for extracorporeal circulation: trial of four anti-inflammatory strategies. Ann Thorac Surg1998; 66: 747-753.

Larsson R , Elgue G , Larsson A et al. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. Immunopharmacology1997; 38: 119-127.

De Somer F , Van Belleghem Y , Caes F et al. Phosphor-ylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion2002; 17: 39-44.